Cargando…
Multivalent display of the antimicrobial peptides BP100 and BP143
Carbohydrates are considered as promising templates for the display of multiple copies of antimicrobial peptides. Herein, we describe the design and synthesis of chimeric structures containing two or four copies of the antimicrobial peptides KKLFKKILKYL-NH(2) (BP100) and KKLfKKILKYL-NH(2) (BP143) at...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520567/ https://www.ncbi.nlm.nih.gov/pubmed/23243472 http://dx.doi.org/10.3762/bjoc.8.237 |
_version_ | 1782252799058247680 |
---|---|
author | Güell, Imma Ferre, Rafael Sørensen, Kasper Kildegaard Badosa, Esther Ng-Choi, Iteng Montesinos, Emilio Bardají, Eduard Feliu, Lidia Jensen, Knud J Planas, Marta |
author_facet | Güell, Imma Ferre, Rafael Sørensen, Kasper Kildegaard Badosa, Esther Ng-Choi, Iteng Montesinos, Emilio Bardají, Eduard Feliu, Lidia Jensen, Knud J Planas, Marta |
author_sort | Güell, Imma |
collection | PubMed |
description | Carbohydrates are considered as promising templates for the display of multiple copies of antimicrobial peptides. Herein, we describe the design and synthesis of chimeric structures containing two or four copies of the antimicrobial peptides KKLFKKILKYL-NH(2) (BP100) and KKLfKKILKYL-NH(2) (BP143) attached to the carbohydrate template cyclodithioerythritol (cDTE) or α-D-galactopyranoside (Galp). The synthesis involved the preparation of the corresponding peptide aldehyde followed by coupling to an aminooxy-functionalized carbohydrate template. After purification, the multivalent display systems were obtained in high purities (90–98%) and in good yields (42–64%). These compounds were tested against plant and human pathogenic bacteria and screened for their cytotoxicity on eukaryotic cells. They showed lower MIC values than the parent peptides against the bacteria analyzed. In particular, the carbopeptides derived from cDTE and Galp, which contained two or four copies of BP100, respectively, were 2- to 8-fold more active than the monomeric peptide against the phytopathogenic bacteria. These results suggest that preassembling antimicrobial peptides to multimeric structures is not always associated with a significant improvement of the activity. In contrast, the carbopeptides synthesized were active against human red blood cells pointing out that peptide preassembly is critical for the hemolytic activity. Notably, peptide preassembly resulted in an enhanced bactericidal effect. |
format | Online Article Text |
id | pubmed-3520567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-35205672012-12-14 Multivalent display of the antimicrobial peptides BP100 and BP143 Güell, Imma Ferre, Rafael Sørensen, Kasper Kildegaard Badosa, Esther Ng-Choi, Iteng Montesinos, Emilio Bardají, Eduard Feliu, Lidia Jensen, Knud J Planas, Marta Beilstein J Org Chem Full Research Paper Carbohydrates are considered as promising templates for the display of multiple copies of antimicrobial peptides. Herein, we describe the design and synthesis of chimeric structures containing two or four copies of the antimicrobial peptides KKLFKKILKYL-NH(2) (BP100) and KKLfKKILKYL-NH(2) (BP143) attached to the carbohydrate template cyclodithioerythritol (cDTE) or α-D-galactopyranoside (Galp). The synthesis involved the preparation of the corresponding peptide aldehyde followed by coupling to an aminooxy-functionalized carbohydrate template. After purification, the multivalent display systems were obtained in high purities (90–98%) and in good yields (42–64%). These compounds were tested against plant and human pathogenic bacteria and screened for their cytotoxicity on eukaryotic cells. They showed lower MIC values than the parent peptides against the bacteria analyzed. In particular, the carbopeptides derived from cDTE and Galp, which contained two or four copies of BP100, respectively, were 2- to 8-fold more active than the monomeric peptide against the phytopathogenic bacteria. These results suggest that preassembling antimicrobial peptides to multimeric structures is not always associated with a significant improvement of the activity. In contrast, the carbopeptides synthesized were active against human red blood cells pointing out that peptide preassembly is critical for the hemolytic activity. Notably, peptide preassembly resulted in an enhanced bactericidal effect. Beilstein-Institut 2012-12-03 /pmc/articles/PMC3520567/ /pubmed/23243472 http://dx.doi.org/10.3762/bjoc.8.237 Text en Copyright © 2012, Güell et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms) |
spellingShingle | Full Research Paper Güell, Imma Ferre, Rafael Sørensen, Kasper Kildegaard Badosa, Esther Ng-Choi, Iteng Montesinos, Emilio Bardají, Eduard Feliu, Lidia Jensen, Knud J Planas, Marta Multivalent display of the antimicrobial peptides BP100 and BP143 |
title | Multivalent display of the antimicrobial peptides BP100 and BP143 |
title_full | Multivalent display of the antimicrobial peptides BP100 and BP143 |
title_fullStr | Multivalent display of the antimicrobial peptides BP100 and BP143 |
title_full_unstemmed | Multivalent display of the antimicrobial peptides BP100 and BP143 |
title_short | Multivalent display of the antimicrobial peptides BP100 and BP143 |
title_sort | multivalent display of the antimicrobial peptides bp100 and bp143 |
topic | Full Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520567/ https://www.ncbi.nlm.nih.gov/pubmed/23243472 http://dx.doi.org/10.3762/bjoc.8.237 |
work_keys_str_mv | AT guellimma multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT ferrerafael multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT sørensenkasperkildegaard multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT badosaesther multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT ngchoiiteng multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT montesinosemilio multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT bardajieduard multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT feliulidia multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT jensenknudj multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 AT planasmarta multivalentdisplayoftheantimicrobialpeptidesbp100andbp143 |